PROK: ProKidney Corp - Class A
PROK exchange rate has changed by -0.43% for today. During the day, the instrument was traded at a low of 2.25 and at a high of 2.37.
Follow ProKidney Corp - Class A dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
PROK News
- H.C. Wainwright initiates ProKidney stock with Buy rating, $12 target
- This MYR Group Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday - Compass Minerals Intl (NYSE:CMP), MYR Group (NASDAQ:MYRG)
- ProKidney: Slow-Burning 'Buy' Opportunity Based On 2027 Approval Of Kidney Disease Therapy
- ProKidney Corp. (PROK) Presents at Morgan Stanley 23rd Annual
- ProKidney at Morgan Stanley Conference: Strategic Insights on CKD Therapy
- ProKidney Corp. (PROK) Presents At Citi's Biopharma Back To School Conference Transcript
- ProKidney at Citi’s Biopharma Back to School Conference: CKD Therapy Progress
- Social Capital's Chamath Palihapitiya is launching a new SPAC — it comes with a jarring warning for retail investors
- Meet the Biotech Stock That Rocketed 775% Higher
- PROKIDNEY CP (PROK) Upgraded to Strong Buy: What Does It Mean for the Stock?
- Best Momentum Stocks to Buy for July 17th
- This Biotech Stock Jumped Over 600% in Just Days After Releasing Promising Clinical Trial Data. And Its Market Cap Is Still Only $2 Billion. But Is It a Buy?
- New Strong Buy Stocks for July 17th
- ProKidney completes Delaware domestication and restructures corporate agreements
- ProKidney Corp. (PROK) is a Great Momentum Stock: Should You Buy?
- ProKidney stock soars after FDA confirms accelerated approval pathway
- Simulations Plus, FB Financial And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Blue Gold (NASDAQ:BGL), FB Financial (NYSE:FBK)
- ProKidney stock falls after FDA alignment on rilparencel approval pathway
- FDA confirms eGFR slope as acceptable endpoint for rilparencel approval
- ProKidney stock price target raised to $8 from $4 at UBS on promising data
- ProKidney stock price target raised to $7 from $6 at Guggenheim
- Core CPI In Focus With JPMorgan, Goldman, Netflix Set To Report Earnings
- AZZ Posts Better-Than-Expected Earnings, Joins MP Materials, WK Kellogg And Other Big Stocks Moving Higher On Thursday - Aehr Test System (NASDAQ:AEHR), Alaska Air Gr (NYSE:ALK)
- Prokidney (PROK) chief regulatory officer Weber sells $312k in stock
Frequently Asked Questions
What is PROK stock price today?
ProKidney Corp - Class A stock is priced at 2.33 today. It trades within 2.25 - 2.37, yesterday's close was 2.34, and trading volume reached 746. The live price chart of PROK shows these updates.
Does ProKidney Corp - Class A stock pay dividends?
ProKidney Corp - Class A is currently valued at 2.33. Dividend policy depends on the company, while investors also watch 43.83% and USD. View the chart live to track PROK movements.
How to buy PROK stock?
You can buy ProKidney Corp - Class A shares at the current price of 2.33. Orders are usually placed near 2.33 or 2.63, while 746 and -1.27% show market activity. Follow PROK updates on the live chart today.
How to invest into PROK stock?
Investing in ProKidney Corp - Class A involves considering the yearly range 0.46 - 7.13 and current price 2.33. Many compare 1.75% and -11.41% before placing orders at 2.33 or 2.63. Explore the PROK price chart live with daily changes.
What are ProKidney Corp - Class A stock highest prices?
The highest price of ProKidney Corp - Class A in the past year was 7.13. Within 0.46 - 7.13, the stock fluctuated notably, and comparing with 2.34 helps spot resistance levels. Track ProKidney Corp - Class A performance using the live chart.
What are ProKidney Corp - Class A stock lowest prices?
The lowest price of ProKidney Corp - Class A (PROK) over the year was 0.46. Comparing it with the current 2.33 and 0.46 - 7.13 shows potential long-term entry points. Watch PROK moves on the chart live for more details.
When did PROK stock split?
ProKidney Corp - Class A has gone through stock splits historically. These changes are visible in , 2.34, and 43.83% after corporate actions.
- Previous Close
- 2.34
- Open
- 2.36
- Bid
- 2.33
- Ask
- 2.63
- Low
- 2.25
- High
- 2.37
- Volume
- 746
- Daily Change
- -0.43%
- Month Change
- 1.75%
- 6 Months Change
- -11.41%
- Year Change
- 43.83%
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- 2.7%
- Prev
- 2.7%
- Act
- Fcst
- 2.6%
- Prev
- 2.6%
- Act
- Fcst
- Prev
- Act
- Fcst
- 325.833
- Prev
- 325.031
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- Act
- Fcst
- Prev
- 4.773%
- Act
- Fcst
- Prev